Text Size

Meibum color and free fatty acid composition in patients with meibomian gland dysfunction

Arita R., Mori N., Shirakawa R., Asai K., Imanaka T., Fukano Y., Nakamur M., Amano S.

  • 2015
  • Investigative Ophthalmology and Visual Science
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Clinical development

  • Affiliations

    Department of Ophthalmology, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan; Department of Ophthalmology, Itoh Clinic, Saitama City, Saitama, Japan; Research and Development Division, Santen Pharmaceutical Co. Ltd, Kita-ku, Osaka, Japan; Inouye Eye Hospital, Chiyoda-ku, Tokyo, Japan; Miyata Eye Hospital, Miyakonojo City, Miyazaki, Japan

Related Publications

Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (NOVATIVE): A Phase II/III, Multicenter, Double-masked, Randomized Study of 0.05% Cyclosporine A and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients With Vernal Keratoconjunctivitis

Leonardi A, Pisella PJ, Benítez-Del-Castillo JM, Amrane M, Ismail D, Doan S, Bremond-Gignac D.

Correlation between gene expression and clinical scores in vernal keratoconjunctivitis

Leonardi A, Cavarzeran F, Rosani U, Righetti G, Garrigue JS, Brun P.

Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials

Leonardi A, Doan S, Aragona P,  Amrane M, Ismail D, Montero J, Németh J, Bremond-Gignac D

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022